KidNaps (Melatonin) 1mg in 1ml Oral Solution
What this means
The MHRA has issued a medicines recall or defect notification. Class 1: risk to life, immediate recall. Class 2: may cause mistreatment or harm, recall within 48 hours. Class 3: unlikely to cause harm, recall within 5 days. Class 4 (defect notification): no recall, caution in use. The medicine remains licensed; only the listed batches are affected. Do not stop treatment without speaking to your doctor or pharmacist.
Class 2 recall · DMRC-38487919
| Product | Licence | Active ingredient | GTIN |
|---|---|---|---|
| KidNaps (Melatonin) 1mg in 1ml Oral Solution | melatonin | 5060191450331 |
Batches (expiry): 200ml (05/11/2024), 200ml (12/11/2024), 200ml (04/02/2025), 200ml (21/02/2025), 200ml (22/04/2025), 200ml (27/06/2025), 200ml (02/09/2025), 200ml (05/11/2025), 200ml (14/12/2025), 200ml (05/02/2026)
Background: Sterling Pharmaceuticals Ltd (specials manufacturer MS 32515) and Veriton Pharma Ltd are recalling all batches of KidNaps (Melatonin) 1mg in 1ml Oral Solution within expiry due to confirmed out of specification results from annual stability testing relating to product appearance and total impurities. Advice for Healthcare Professionals: Stop supplying the above batches immediately. Quarantine all stock and return it to your supplier using your supplier’s approved process.